Simon, Judit
Mikhael, Peter
Tahir, Ismail
Graur, Alexander
Ringer, Stefan
Fata, Amanda
Jeffrey, Yang Chi-Fu
Shepard, Jo-Anne
Jacobson, Francine
Barzilay, Regina
Sequist, Lecia V.
Pace, Lydia E.
Fintelmann, Florian J.
Article History
Received: 31 August 2023
Accepted: 22 October 2023
First Online: 30 October 2023
Competing interests
: Regina Barzilay has Consulting or advisory roles at Dewpoint Therapeutics, J&J, Amgen, Outcomes4Me, Immunai, and Firmenich. Lecia Sequist has consulting or advisory roles with AstraZeneca, Janssen, Takeda and research funding from Novartis, AstraZeneca, and Delfi. She is leading a clinical demonstration project funded by Grail and Point32 Health. Florian Fintelmann reports research funding from Pfizer, as well as consultant and speaker fees from Boston Scientific. The other authors declare no relevant conflicts of interest.